| Q33644800 | A comprehensive dosimetric study on switching from a Type-B to a Type-C dose algorithm for modern lung SBRT |
| Q47877896 | A phase I/II study on stereotactic body radiotherapy with real-time tumor tracking using CyberKnife based on the Monte Carlo algorithm for lung tumors |
| Q35710889 | Adapted Prescription Dose for Monte Carlo Algorithm in Lung SBRT: Clinical Outcome on 205 Patients |
| Q33645619 | Advances in radiotherapy techniques and delivery for non-small cell lung cancer: benefits of intensity-modulated radiation therapy, proton therapy, and stereotactic body radiation therapy |
| Q36468246 | Algorithms used in heterogeneous dose calculations show systematic differences as measured with the Radiological Physics Center's anthropomorphic thorax phantom used for RTOG credentialing |
| Q90105657 | Assessment of biological dosimetric margin for stereotactic body radiation therapy |
| Q35150641 | Clinical analysis of stereotactic body radiation therapy using extracranial gamma knife for patients with mainly bulky inoperable early stage non-small cell lung carcinoma |
| Q38178429 | Clinical introduction of Monte Carlo treatment planning for lung stereotactic body radiotherapy |
| Q48705863 | Combination effects of tissue heterogeneity and geometric targeting error in stereotactic body radiotherapy for lung cancer using CyberKnife |
| Q37109928 | Comparing the clinical outcomes in stereotactic body radiotherapy for lung tumors between Ray-Tracing and Monte-Carlo algorithms |
| Q38187550 | Correlation between target volume and electron transport effects affecting heterogeneity corrections in stereotactic body radiotherapy for lung cancer |
| Q49989260 | Credentialing of radiotherapy centres in Australasia for TROG 09.02 (Chisel) a Phase III clinical trial on stereotactic ablative body radiotherapy of early stage lung cancer. |
| Q36661346 | Differences in the dose-volume metrics with heterogeneity correction status and its influence on local control in stereotactic body radiation therapy for lung cancer |
| Q44560526 | Dose calculation differences between Monte Carlo and pencil beam depend on the tumor locations and volumes for lung stereotactic body radiation therapy |
| Q36555610 | Dose correction in lung for HDR breast brachytherapy |
| Q40176468 | Dose differences in intensity-modulated radiotherapy plans calculated with pencil beam and Monte Carlo for lung SBRT. |
| Q52561222 | Dose gradient curve: A new tool for evaluating dose gradient. |
| Q61446980 | Dose prescription with spatial uncertainty for peripheral lung SBRT |
| Q51403225 | Dosimetric comparison of robotic and conventional linac-based stereotactic lung irradiation in early-stage lung cancer. |
| Q42150664 | Dosimetric comparison of three-dimensional conformal radiotherapy, intensity modulated radiotherapy, and helical tomotherapy for lung stereotactic body radiotherapy |
| Q36724932 | Dosimetric evaluation of a simple planning method for improving intensity-modulated radiotherapy for stage III lung cancer |
| Q89624789 | Dosimetric evaluation of incorporating the revised V4.0 calibration protocol for breast intraoperative radiotherapy with the INTRABEAM system |
| Q33837224 | Dosimetric evaluation of synthetic CT for magnetic resonance-only based radiotherapy planning of lung cancer |
| Q36010763 | Dosimetric verification using monte carlo calculations for tissue heterogeneity-corrected conformal treatment plans following RTOG 0813 dosimetric criteria for lung cancer stereotactic body radiotherapy |
| Q52609421 | Dosimetrical and radiobiological approach to manage the dosimetric shift in the transition of dose calculation algorithm in radiation oncology: how to improve high quality treatment and avoid unexpected outcomes? |
| Q37022255 | Effectiveness of the Monte Carlo method in stereotactic radiation therapy applied to quasi-homogenous brain tumors |
| Q39820035 | Esophageal cancer dose escalation using a simultaneous integrated boost technique |
| Q51286974 | Evaluation of 4D dose to a moving target with Monte Carlo dose calculation in stereotactic body radiotherapy for lung cancer. |
| Q48944841 | Evaluation of dose prediction error and optimization convergence error in four-dimensional inverse planning of robotic stereotactic lung radiotherapy |
| Q40105418 | Evaluation of pencil beam convolution and anisotropic analytical algorithms in stereotactic lung irradiation |
| Q47097838 | Evaluation of ray tracing and Monte Carlo algorithms in dose calculation and clinical outcomes for robotic stereotactic body radiotherapy of lung cancers |
| Q99582898 | Four-year follow-up outcomes after stereotactic body radiation therapy for central early-stage non-small cell lung cancer |
| Q34381901 | GTV-based prescription in SBRT for lung lesions using advanced dose calculation algorithms |
| Q30493924 | Imaging primary lung cancers in mice to study radiation biology. |
| Q38272276 | Impact of dose calculation algorithm on radiation therapy |
| Q37698823 | Low incidence of chest wall pain with a risk-adapted lung stereotactic body radiation therapy approach using three or five fractions based on chest wall dosimetry |
| Q55073350 | Lung SBRT: dosimetric and delivery comparison of RapidArc, TomoTherapy, and IMRT. |
| Q33758565 | No clinically significant changes in pulmonary function following stereotactic body radiation therapy for early- stage peripheral non-small cell lung cancer: an analysis of RTOG 0236 |
| Q49749018 | Optimizing the prescription isodose level in stereotactic volumetric-modulated arc radiotherapy of lung lesions as a potential for dose de-escalation |
| Q95841272 | Radiation-Induced Secondary Cancer Risk Assessment in Patients With Lung Cancer After Stereotactic Body Radiotherapy Using the CyberKnife M6 System With Lung-Optimized Treatment |
| Q92973685 | Risk-adapted stereotactic body radiation therapy for central and ultra-central early-stage inoperable non-small cell lung cancer |
| Q98771302 | Significant Correlation Between Overall Survival and Mean Lung Dose in Lung Stereotactic Body Radiation Therapy (SBRT) |
| Q47891076 | Small field dose measurements using plastic scintillation detector in heterogeneous media. |
| Q56523398 | Stereotactic Body Radiation Therapy for Operable Early-Stage Lung Cancer: Findings From the NRG Oncology RTOG 0618 Trial |
| Q35667834 | Stereotactic ablative radiotherapy (SABR) for lung cancer: What does the future hold? |
| Q34010065 | Stereotactic body radiation therapy for inoperable early stage lung cancer |
| Q60912983 | Stereotactic body radiation therapy for non-small cell lung cancer: A review |
| Q64922876 | Stereotactic body radiation therapy versus surgery for early stage non-small cell lung cancer: clearing a path through an evolving treatment landscape. |
| Q42033188 | Stereotactic body radiotherapy for small lung tumors in the University of Tokyo Hospital |
| Q38175120 | Stereotactic body radiotherapy: a critical review for nonradiation oncologists |
| Q36644220 | The effect of beam arrangements and the impact of non-coplanar beams on the treatment planning of stereotactic ablative radiation therapy for early stage lung cancer |
| Q47734152 | The impact of technology on the changing practice of lung SBRT. |